Determination of Visfatin Level in Patients with Diabetes and Peripheral Neuropathy as Early Predicted Factor

Peripheral neuropathy represents one of the common diabetic complications in patients with diabetes mellitus type 2 (DMT2). affects feet, legs, hands, and arms. It was found that one-third to one-half diabetics have peripheral neuropathy. The current study aimed evaluate level visfatin patient groups or without comparison healthy subjects knowledge whether can be applied as a predictor factor for this disease complication. included 120 males females ranging age from 40 97 years old. (40 diabetes, neuropathy, people served control group.) All had verified diagnosis (type 2). During period October 2021 December 2021, were assessed at National Diabetes Center, Al-Mustansiriya University Baghdad. Visfatin levels tested using ELISA technique, HbA1c Cobas C111. In patients, HbA1C are significantly higher (p≤0.05) than controls. Males DPN DM greater mean values group. strong indications early both females, according study.